Jun 9, 2022

Treosulfan Pivotal Study Results: Medexus Pharmaceuticals

Jun 6, 2022

Treosulfan Pivotal Study Results Published

May 26, 2022

Toronto Stock Exchange, Medexus Pharmaceuticals, The View From The C-Suite

Mar 2, 2022

Why Medexus is a LEADER in Rare Disease Treatment Solutions

Mar 1, 2022

Medexus Pharmaceuticals has a 66 per cent upside, says Research Capital

Dec 27, 2021

Medexus Pharmaceuticals Inc. (TSX: MDP) (OTCQX: MEDXF) Webcast (December 2021) | SNN Network

Nov 15, 2021

Medexus Provides Fiscal Q2 2022 Summary, Full Product Line Update and 2022 Growth Drivers

Aug 5, 2021

Webinar Discussion on Complete Response Letter from FDA for Treosulfan

Aug 28, 2019

Full interview: Medexus Pharmaceuticals unveils jump in 1Q revenue, increased earnings

Aug 26, 2019

Full interview: Discovery Investment Research analyst says Medexus Pharmaceuticals has a solid business

• 1
• 2
• Next »